跳至主要内容
临床试验/NCT05236283
NCT05236283已完成不适用

Duration of Antimicrobial Treatment for Bloodstream Infections in Swiss Critically Ill Patients - Retrospective Double Center Study

Insel Gruppe AG, University Hospital Bern1 个研究点 分布在 1 个国家目标入组 395 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
395
试验地点
1
主要终点
Antibiotic Treatment Duration

研究概览

简要总结

The objectives of the retrospective cohort study is to describe the actual current practice of antibiotic treatment duration for bloodstream infections in critically ill patients at two tertiary hospitals (ICU Inselspital Bern and ICU CHUV Lausanne), to examine patient, pathogen and infectious syndrome factors associated with selection of shortened treatment duration, and to describe the expected time course of clinical resolution among bacteremic patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has a positive blood culture with a pathogenic organism Patient is critically ill at the time the blood culture was collected as defined by the following:
  • was treated at the ICU/IMC at the time of blood culture collection;
  • or has been admitted to ICU/IMC in the 48 hours after blood culture collection

排除标准

  • Patient has a single positive blood culture with a common contaminant organism:
  • coagulase negative staphylococci;
  • Bacillus spp.;
  • Corynebacterium spp.;
  • Propionibacterium spp.;
  • Aerococcus spp.;
  • Micrococcus spp.
  • Explicit documentation that the patient does not want to participate in any study

结局指标

主要结局

Antibiotic Treatment Duration

时间窗: Hospital discharge, expected to be on average ca. 15-20 days

Days of adequate antibiotic treatment in Patients with Bacteremia

次要结局

  • Days of hospital stay(Hospital discharge, expected to be on average ca. 15-25 days)
  • Days of ICU stay(ICU discharge, expected to be on average ca. 5-15 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验